Thyroid Nodule Evaluation
Thyroid nodule evaluation determines whether a lump in the thyroid needs monitoring, biopsy, treatment, or nothing at all — most nodules are benign.
This service provides systematic, guideline-based assessment.
Last medically reviewed: 1 November 2025
The evaluation pathway
Evaluation combines TSH testing (to check function and exclude toxic nodules), ultrasound (to characterise structure and risk), and FNAC when criteria are met. This systematic approach identifies the small minority needing intervention.
Nodule size, ultrasound features, patient age, and risk factors all inform the recommendation.
Possible outcomes
Benign: monitoring with periodic ultrasound. Suspicious: FNAC or surgical referral. Toxic: treatment for hormone excess. Compressive: surgical evaluation. Cancer: staging and treatment planning.
You receive a clear explanation of why each recommendation is made.
Who benefits
Anyone with a palpable or ultrasound-detected nodule, abnormal thyroid tests suggesting nodular disease, or a history of neck radiation or family thyroid cancer.
Frequently asked questions
Do all nodules need biopsy?
No — FNAC is recommended only for nodules meeting size and risk criteria. Most small, benign-appearing nodules are monitored.
How often should benign nodules be checked?
Typically every 6–12 months initially, then less frequently if stable — the interval depends on ultrasound features and clinical factors.
What if I have multiple nodules?
Each nodule is evaluated individually — the most suspicious one determines whether biopsy is needed, while others may be monitored.
References & further reading
This page is based on established medical knowledge and guidelines from authoritative sources. Always consult a qualified clinician for personal medical advice.
Ready to discuss your thyroid health?
Book a specialist consultation — in person or by teleconsultation.